Establishment Labs (ESTA) vs Materion (MTRN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Materion (MTRN) has outperformed Establishment Labs (ESTA) over the past year, gaining 118.4% versus a gain of 51.1%. Over five years, MTRN leads with a +284.3% price change compared with -21.3% for ESTA. Materion is the larger company by market cap ($5.88 billion vs $1.84 billion), about 3.2 times the size, while Establishment Labs is growing revenue faster (+27.1% vs +6.0%).
On valuation, Materion trades at a lower forward P/E (33.5x vs 1029.3x for Establishment Labs). Materion pays a dividend yielding 0.20%, while Establishment Labs does not currently pay one. Materion converts more of its revenue into profit, with a net margin of 4.2% versus -24.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ESTA | MTRN |
|---|---|---|
| Share price | $61.76 | $282.18 |
| Market cap | $1.84B | $5.88B |
| 1-day change | +1.90% | +1.83% |
| YTD return | -16.84% | +122.90% |
| 1-year return | +51.07% | +118.44% |
| 5-year return | -21.29% | +284.29% |
| P/E ratio (TTM) | — | 65.78 |
| Forward P/E | — | 33.46 |
| EPS (TTM) | $-1.30 | $4.29 |
| Dividend yield | 0.00% | 0.20% |
| Annual dividend | $0.00 | $0.565 |
| Revenue (latest FY) | $211.08M | $1.79B |
| Revenue growth (YoY) | +27.14% | +6.04% |
| Net income (latest FY) | $-51.06M | $74.82M |
| Gross margin | 69.32% | 17.27% |
| Operating margin | -18.48% | 6.15% |
| Net margin | -24.19% | 4.19% |
| 52-week high | $97.59 | $324.99 |
| 52-week low | $38.38 | $109.61 |
| Distance from 52-week high | -36.71% | -13.17% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +65.87% | +7.64% |
| Average volume | 427.13K | 315.57K |
| Shares outstanding | 29.80M | 20.83M |
| Employees | 1,004 | 3,000 |
| Sector | Health Care | Industrials |
| Industry | Industrial Specialties | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Materion is about 3.2 times larger than Establishment Labs by market value ($5.88B vs $1.84B).
- MTRN has outperformed ESTA by 67.4 percentage points over the past year.
- Materion is more profitable, keeping 4.2 cents of every revenue dollar as net income versus -24.2 cents for Establishment Labs.
- Establishment Labs grew revenue faster in its latest fiscal year (+27.14% vs +6.04%).
- The two companies sit in different sectors: Establishment Labs in Health Care and Materion in Industrials.
About Establishment Labs
ESTA stock →Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand.
Health Care · Industrial Specialties · 1,004 employees
About Materion
MTRN stock →Materion Corporation, together with its subsidiaries, produces advanced engineered materials in the United States, Asia, Europe, and internationally. The company operates in four segments: Performance Materials, Electronic Materials, Precision Optics, and Other.
Industrials · Industrial Specialties · 3,000 employees
ESTA vs MTRN FAQ
Which is bigger, Establishment Labs or Materion?
Materion (MTRN) is larger, with a market capitalization of $5.88B compared with $1.84B for Establishment Labs (ESTA).
Which stock has performed better over the past year, ESTA or MTRN?
MTRN returned +118.44% over the past 12 months, compared with +51.07% for ESTA (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Establishment Labs or Materion?
Materion pays a dividend yielding 0.20%, while Establishment Labs does not currently pay a regular dividend.
Are Establishment Labs and Materion in the same industry?
Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.